Stock DNA
Software Products
INR 2,402 Cr (Small Cap)
15.00
27
1.41%
-0.43
19.00%
2.80
Total Returns (Price + Dividend) 
Latest dividend: 12.5 per share ex-dividend date: Jul-11-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Nucleus Soft. Sees Revision in Market Evaluation Amid Mixed Financial Signals
Nucleus Soft., a small-cap player in the Software Products sector, has experienced a revision in its market evaluation reflecting a shift in analytical perspective. This adjustment follows a detailed review of the company’s recent financial performance, valuation, and technical indicators, highlighting a complex picture for investors navigating the stock’s trajectory.
Read More
Nucleus Software Exports Faces Bearish Momentum Amid Technical Shifts
Nucleus Software Exports has experienced a notable shift in its technical momentum, reflecting a bearish trend across multiple timeframes. The stock’s recent price action and technical indicators suggest a cautious outlook as it navigates downward pressure amid broader market dynamics.
Read More
Nucleus Software Exports Forms Death Cross Signalling Potential Bearish Trend
Nucleus Software Exports has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average, often interpreted as a signal of weakening momentum and potential bearish trend ahead. This development comes amid a series of underwhelming performance metrics relative to broader market benchmarks, raising questions about the stock’s near-term trajectory within the Software Products sector.
Read More Announcements 
Board Meeting Intimation for Notice Of Board Meeting
21-Jan-2026 | Source : BSENucleus Software Exports Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve This is to inform you that a Meeting of the Board of Directors of the Company would be held on Tuesday February 10 2026 for the following purpose: a) For Approval and Adoption of the Audited Standalone Financial results of the Company for the Quarter and Nine months ending December 31 2025; b) For Approval and Adoption of the Unaudited Consolidated Financial results of the Company for the Quarter and Nine months ending December 31 2025; The financial results duly approved by the Board of Directors shall be declared at the conclusion of the Board Meeting on February 10 2026.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21-Jan-2026 | Source : BSEThis is to inform you that the Investor/Analyst Earning Conference Call of the Company would be held on Wednesday February 11 2026 During such call the management will comment on the financial results for the Quarter and Nine month ended December 31 2025 and answer the queries as may be raised by the participants. Details of the call is enclosed and is published on the Companys website.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSEPlease find enclosed herewith the Intimation
Corporate Actions 
No Upcoming Board Meetings
Nucleus Software Exports Ltd has declared 125% dividend, ex-date: 11 Jul 25
No Splits history available
Nucleus Software Exports Ltd has announced 1:1 bonus issue, ex-date: 03 Aug 07
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (1.18%)
Held by 68 FIIs (4.91%)
Karmayogi Holdings Private Limited (33.59%)
Barca Global Master Fund, Lp (1.82%)
16.98%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -1.93% vs -4.91% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -25.31% vs -45.65% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 8.46% vs -3.51% in Sep 2024
Growth in half year ended Sep 2025 is -2.80% vs -35.55% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -2.09% vs 43.88% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -29.56% vs 131.89% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 0.70% vs 30.26% in Mar 2024
YoY Growth in year ended Mar 2025 is -14.93% vs 49.93% in Mar 2024